Reversible Biotinylation of the 5′‐Terminus of Oligodeoxyribonucleotides and its Application in Affinity Purification by Fang, Shiyue & Bergstrom, Donald E.
UNIT 4.20Reversible Biotinylation of the 5′-Terminus of
Oligodeoxyribonucleotides and Its
Application in Affinity Purification
In UNIT 4.2, several methods for biotinylation of DNA are described (see structures 95b,
96, 101, 104a, 106, and 124a-c in that unit). Except for structure 124c, in which the biotin
moiety can be removed nondestructively by UV irradiation, other biotinylation methods
are irreversible. UNIT 4.3 presents protocols for direct attachment of acridine and psoralen
derivatives to the 5′-terminus of DNA via their phosphoramidites. In this unit, protocols
are given for the preparation of two reversible biotinylation phosphoramidites for direct
labeling of the 5′-terminus of DNA (see Basic Protocols 1 and 2 and Support Protocol 2)
and their applications in NeutrAvidin-coated microsphere-mediated affinity purification
of synthetic oligodeoxyribonucleotides (see Support Protocol 1). The DNAs synthesized
using these two phosphoramidites feature a diisopropyl silyl acetal linkage between biotin
and their 5′-termini; these linkages can be readily broken by fluoride ions. The first of the
two phosphoramidites yields 5′-OH unmodified DNA upon treatment with HF/pyridine,
while the second phosphoramidite yields 5′-phosphate DNA on treatment with HF/pyri-
dine followed by aqueous methylamine.
CAUTION: All chemicals must be handled in a well-ventilated fume hood by individuals
equipped with laboratory coats, safety glasses, and gloves.
BASIC
PROTOCOL 1
REVERSIBLE BIOTINYLATION VIA A DIISOPROPYL SILYL ACETAL
LINKER YIELDING 5′-OH DNA
This protocol describes the preparation of the reversible biotinylation phosphoramidite
S.3 (see Fig. 4.20.1), its coupling to the 5′-end of DNA on an automatic solid-phase
synthesizer, and postsynthetic cleavage/deprotection to afford the biotinylated DNA S.4
(see Fig. 4.20.1). A sample sequence is shown in S.5. Other appropriately protected
deoxyribonucleosides, such as N6-benzoyldeoxyadenosine, N2-isobutyryldeoxyguanos-
ine, and N4-acetyldeoxycytosine, should be able to be biotinylated using the same
procedure.
Materials
Biotinyl alcohol S.1 (see Support Protocol 2 for preparation)
Imidazole (99%)
Argon and nitrogen gas
N,N-Dimethylformamide (DMF, anhydrous)
Diisopropylethylamine (DIEA)
Diisopropyldichlorosilane (Fluka)
Thymidine (99%+)
Ethyl acetate
5% (w/v) sodium bicarbonate (NaHCO3)
Sodium sulfate (Na2SO4, anhydrous)
Chloroform (CHCl3)
Methanol
40-µm silica gel (Baker)
TLC plates: silica gel on aluminum (60F-254, 200-µm thickness)
Methylene chloride (CH2Cl2, anhydrous)
2-Cyanoethyl-N,N,N′,N′-tetraisopropylphosphoramidite (2-cyanoethyl-
tetraisopropylphosphorodiamidite, 97%)
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4.20.1
Synthesis of
Modified
Oligonucleotides
and Conjugates
1H-Tetrazole (99%+, sublimed)
Tetrahydrofuran (THF, 99%+)
5′-DMTr, 2-cyanoethyl phosphoramidite monomers:
 5′-O-dimethoxytrityl-N6-benzoyl-2′-deoxyadenosine-3′-(2-cyanoethyl-N,N-di- 
 isopropyl)phosphoramidite (dABz)
 5′-O-dimethoxytrityl-N2-isobutyryl-2′-deoxyguanosine-3′-(2-cyanoethyl-N,N-di-
 isopropyl)phosphoramidite (dGi-Bu)
 5′-O-dimethoxytrityl-N4-acetyl-2′-deoxycytidine-3′-(2-cyanoethyl-N,N-diisopro-
 pyl)phosphoramidite (dCAc)
5′-O-dimethoxytrityl-2′-deoxythymidine-3′-(2-cyanoethyl-N,N-diisopropyl)phos-
 phoramidite (T)
Acetonitrile (CH3CN, anhydrous)
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1. i-Pr2SiCl2, imidazole, DIEA
2. thymidine, imidazole
2 (92%)
3 (85%)
4
5
(i-Pr2N)2POCH2CH2CN,
1H-tetrazole
TACAGTGACT OH
O
35 ′ ′
Figure 4.20.1 Preparation of reversible biotinylation phosphoramidite S.3 and structures of  biot-
inylated 5′-OH DNAs S.4 and S.5.
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∼29% (v/v) ammonium hydroxide (NH4OH)
∼40% (v/v) methylamine (CH3NH2)
50-mL one-neck round-bottomed flasks (oven dried)
Vacuum pump
10-, 5-, 1-, 0.25-mL graduated glass syringes
20-G, 5-cm stainless steel needles
Septa (14/20, 24/40)
250-mL separatory funnel
Filter funnel and Whatman no. 1 filter paper
Rotary evaporator equipped with a water aspirator
Flash chromatography columns (4.5 × 12–cm, 3.0 × 12–cm)
UV lamp
5-mL screw-cap vials
Speedvac evaporator
Additional reagents and equipment for thin-layer chromatography (TLC, APPENDIX
3D), column chromatography (APPENDIX 3E), solid-phase automatic DNA
synthesis (APPENDIX 3C) using classical phosphoramidite method (UNIT 3.3), and
purification of oligonucleotides by SDS-PAGE (UNIT 10.4) and reversed-phase
HPLC (UNIT 10.5)
Prepare biotinyl thymidine S.2
1. Dry 1.7 g (2.62 mmol) biotinyl alcohol S.1 in a 50-mL one-neck round-bottomed
flask (equipped with a magnetic stir bar) under vacuum overnight at room tempera-
ture.
2. Add 211 mg (3.1 mmol) imidazole and then flush the flask with an argon flow for 10
min.
3. Add 5 mL of dry DMF and 2.7 mL (15.5 mmol) DIEA with 10-mL and 5-mL glass
syringes attached to 20-G stainless steel needles, respectively, and cool the mixture
to 0°C.
4. Add 839 µL (4.65 mmol) diisopropyldichlorosilane with a 1-mL glass syringe in one
portion. Stir the mixture at 0°C for 1 hr, then at room temperature for 4 hr on a
magnetic stir plate.
The tertiary hydroxyl group in S.1 substitutes one of the two chlorine atoms in diiso-
propyldichlorosilane; the other chlorine atom will be substituted by the primary hydroxyl
group of thymidine in the next step.
5. In another 50-mL oven-dried, one-neck round-bottomed flask, place 1.5 g (6.2 mmol)
thymidine and 422 mg (6.2 mmol) imidazole. Seal the flask with a septum, flush with
argon gas for ∼10 min, and then add 5 mL dry DMF with a 20-G needle attached to
a 10-mL glass syringe. Shake and dissolve the solids.
6. Cool the solution prepared in step 4 to 0°C. Add the solution prepared in step 5 with
a 10-mL glass syringe and stir the mixture at 0°C for 4 hr.
7. Add 50 mL ethyl acetate and 50 mL of 5% NaHCO3, transfer the mixture to a 250-mL
separatory funnel, and separate the organic phase.
8. Extract the aqueous phase four times with 50 mL ethyl acetate.
9. Combine the organic phases, dry over ∼2 g anhydrous Na2SO4, and filter off the solids
using a filter funnel and Whatman no. 1 filter paper. Concentrate the filtrate to dryness
on a rotary evaporator with a water aspirator.
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10. Dissolve the residue in ∼10 mL of 9:1 (v/v) CHCl3/methanol and apply to the top of
a 4.5 × 12–cm flash chromatography column (APPENDIX 3E) prepared with a slurry of
40-µm silica gel in the same solvent system. Elute the column with the same solvent
system. Monitor the fractions by TLC (APPENDIX 3D).
11. Pool the fractions that contain the UV-active spot with an Rf = 0.4 (9:1 CHCl3/metha-
nol), concentrate to dryness on a rotary evaporator, and then dry under vacuum.
S.2 is obtained with an expected yield of 92% (2.49 g). 1H NMR (CD3OD, 500 MHz) δ
0.91-1.05 (m, 14H), 1.19 (s, 6H), 1.28 (s, 9H), 1.28-1.29 (m, 1H), 1.40-1.43 (m, 2H),
1.58-1.83 (m, 5H), 1.81 (s, 3H), 2.12-2.30 (m, 4H), 2.94-3.05 (m, 2H), 3.25-3.33 (m, 5H),
3.46-3.51 (m, 4H), 3.56-3.57 (m, 4H), 3.90-4.00 (m, 3H), 4.23 (dd, 1H, J = 4.5, 7.7 Hz),
4.38-4.40 (m, 1H), 5.13 (dd, 1H, J = 4.8, 7.7 Hz), 7.37 (d, 2H, J = 8.1 Hz), 7.44 (d, 2H, J
= 8.4 Hz), 7.47 (s, 1H); 13C NMR (CD3OD, 500 MHz) δ 12.7, 14.5, 14.7, 18.3, 18.3, 18.3,
18.4, 26.8, 29.4, 29.5, 29.8, 30.2, 31.6, 32.1, 32.5, 35.8, 36.7, 38.8, 40.2, 40.3, 41.0, 41.5,
56.0, 56.6, 59.2, 64.0, 64.1, 70.5, 70.6, 71.3, 71.9, 74.8, 86.0, 88.5, 111.5, 125.5, 129.7,
133.6, 137.5, 152.2, 156.0, 158.0, 166.2, 171.7, 176.0, 176.2, 211.4.
Prepare biotinyl thymidine phosphoramidite S.3
12. Dry 220 mg (0.22 mmol) S.2 in a 50-mL oven-dried, one-neck round-bottomed flask
(equipped with a magnetic stir bar) under vacuum overnight at room temperature.
13. Flush the flask with an argon flow for ∼5 min, then add (in order) 5 mL dry CH2Cl2
and 76 µL (0.23 mmol) of 2-cyanoethyl-N,N,N′,N′-tetraisopropylphosphoramidite
with 10-mL and 250-µL, respectively, glass syringes. Stir the mixture at room
temperature until it becomes a clear solution.
14. Add 15.4 mg (0.22 mmol) of 1H-tetrazole in three portions over a period of 1 hr. For
each addition, open the neck slightly, quickly add with a spatula, and then stop the
flask immediately to minimize the introduction of air into the flask.
15. Stir the reaction mixture for an additional 4 hr, and then concentrate to ∼2 mL on a
rotary evaporator.
16. Apply the suspension to the top of a 3.0 × 12–cm flash chromatography column
prepared with a slurry of silica gel in 1:1 (v/v) CHCl3/THF. Elute the column with
the same solvent system and monitor the fractions by TLC.
17. Pool the fractions that contain the UV-active spot with an Rf = 0.3 (1:1 CHCl3/THF),
remove solvents on a rotary evaporator, and dry the product under vacuum.
S.3 is obtained as a white foam with an expected yield of 85% (225 mg). 1H NMR (CDCl3,
250 MHz) δ 0.99–1.13 (m, 14H), 1.24 (d, 12H, J = 6.8 Hz), 1.28 (s, 6H), 1.36 (s, 9H),
1.36–1.90 (m, 8H), 1.90 (s, 3H), 2.21–2.39 (m, 6H), 2.75 (dt, 2H, J = 2.0, 5.8 Hz), 3.07–3.10
(m, 2H), 3.32–3.42 (m, 5H), 3.55–3.60 (m, 4H), 3.65 (s, 4H), 3.62–3.92 (m, 4H), 4.01–4.09
(m, 3H), 4.28–4.33 (m, 1H), 4.68–4.72 (m, 1H), 5.20–5.24 (m, 1H), 6.30 (t, 1H, J = 7.5
Hz), 7.49 (d, 4H, J = 7.8 Hz), 7.59 (s, 1H); 31P NMR (CDCl3, 250 MHz) δ 149.7, 149.8.
Couple phosphoramidite S.3 to 5′-end of oligodeoxyribonucleotide
18. Using the 5′-DMTr, 2-cyanoethyl phosphoramidites and following the classical
phosphoramidite method (UNIT 3.3, APPENDIX 3C), synthesize the desired oligodeoxyri-
bonucleotide on a DNA synthesizer. After completion, perform an additional detrityl-
ation step.
For the example in Figure 4.20.1 (S.5), the sequence 3′-TCAGTGACA-5′ was synthesized
on a 1-mol scale.
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19. Place a solution of phosphoramidite S.3 (0.1 M in dry acetonitrile) on the synthesizer.
Carry out coupling by recycling a mixture of 0.1 mL phosphoramidite solution and
0.5 mL of 1H-tetrazole solution (0.45 M in dry acetonitrile) for 15 min.
20. Remove the excess coupling reagents and perform iodine oxidation according to the
standard procedure (UNIT 3.3, APPENDIX 3C). Dry the product on CPG under nitrogen
flow.
Cleave and deprotect biotinylated oligonucleotide
21. Place the oligonucleotide-bound CPG in a 5-mL screw-cap vial, add 500 µL of ∼29%
NH4OH and 500 µL of ∼40% methylamine, and heat the suspension to 65°C for 30
min.
22. Cool the vial to –20°C, remove the supernatant, and save. Wash the CPG three times
with 500 µL water, keeping all washes. Combine the supernatant and water washes,
and dry on a Speedvac evaporator.
23. Purify the biotinylated DNA by gel electrophoresis or reversed-phase HPLC accord-
ing to procedures in UNIT 10.4 and UNIT 10.5, respectively.
The HPLC profile of crude biotinylated DNA S.5 (see Fig. 4.20.1) is illustrated in Figure
4.20.2.
BASIC
PROTOCOL 2
REVERSIBLE BIOTINYLATION VIA A DIISOPROPYL SILYL ACETAL
LINKER YIELDING 5′-PHOSPHATE DNA
This protocol describes the preparation of the reversible biotinylation phosphoramidites
S.7 (see Fig. 4.20.3), its coupling to the 5′-end of DNA on a solid-phase synthesizer, and
postsynthetic cleavage/deprotection to afford the biotinylated DNA S.8 (Fig. 4.20.3). A
sample sequence is shown in S.9.
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Figure 4.20.2 HPLC profiles of DNAs S.5 (trace a), 5′-TACAGTGACT-3′ (trace b), S.9 (trace c),
and 5′-H2O3PO-ACAGTGACT-3′ (trace d) generated on a C18 reversed-phase column (100 Å, 250
× 4.6 mm, Varian Analytical Instruments), using a linear gradient of 0% to 45% solvent B (90%
acetonitrile) in solvent A (0.1 M triethylammonium acetate, 5% acetonitrile) over 60 min at a flow
rate of 1 mL/min by detecting the absorbance of DNA at 260 nm. For a detailed protocol for
performing reversed-phase HPLC, refer to UNIT 10.5.
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Materials
Biotinyl alcohol S.1 (see Support Protocol 2 for preparation)
Imidazole (99%)
Argon and nitrogen gas
N,N-Dimethylformamide (DMF, anhydrous)
Diisopropylethylamine (DIEA)
Diisopropyldichlorosilane (Fluka)
Diethyl bis(hydroxymethyl)malonate (97%)
Methylene chloride (CH2Cl2)
5% (v/v) citric acid
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Figure 4.20.3 Preparation of reversible biotinylation phosphoramidite S.7 and structures of  biot-
inylated 5′-phosphate DNAs S.8 and S.9.
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Sodium sulfate (Na2SO4, anhydrous)
Chloroform (CHCl3)
Methanol
40-µm silica gel (Baker)
TLC plates: silica gel on aluminum (60F-254, 200-µm thickness)
Acetonitrile (distilled over CaH2)
2-Cyanoethyl-N,N,N′,N′-tetraisopropylphosphoramidite (2-cyanoethyl-
tetraisopropylphosphorodiamidite, 97%)
0.45 M 1H-tetrazole (99%+, sublimed) in acetonitrile
5% (w/v) sodium bicarbonate (NaHCO3)
Tetrahydrofuran (THF, 99%+)
Triethylamine (TEA)
50-mL one-neck, round-bottomed flasks (oven dried)
Vacuum pump
20-G, 5-cm stainless steel needles
5-, 1-, and 0.5-mL graduated glass syringes
Septa (14/20, 24/40)
250-mL separatory funnels
Filter funnel and Whatman no. 1 filter paper
Rotary evaporator equipped with a water aspirator
Flash chromatography columns (3.0 × 12–cm, 3.0 × 10–cm)
UV lamp
Additional reagents and equipment for thin-layer chromatography (TLC, APPENDIX
3D), column chromatography (APPENDIX 3E), and incorporation of biotinylated
phosphoramidite into oligonucleotide (see Basic Protocol 1)
Prepare biotin diethyl bis(hydroxymethyl)malonate conjugate S.6
1. Dry 605 mg (0.93 mmol) biotinyl alcohol S.1 in a 50-mL oven-dried, one-neck,
round-bottomed flask (equipped with a magnetic stir bar) under vacuum overnight
at room temperature.
2. Add 63 mg (0.93 mmol) imidazole and then flush the flask with an argon flow for 10
min.
3. Add 2 mL of dry DMF and 498 µL (2.79 mmol) DIEA with a 20-G needle attached
to a 5-mL and 1-mL glass syringe, respectively, and cool the mixture to 0°C.
4. Add 252 µL (1.40 mmol) diisopropyldichlorosilane with a 500-µL glass syringe in
one portion. Stir the mixture at 0°C for 1 hr, then at room temperature for 4 hr on a
magnetic stir plate.
5. In another 50-mL oven-dried, one-neck, round-bottomed flask, place 500 mg (2.20
mmol) diethyl bis(hydroxymethyl)malonate and 126 mg (1.86 mmol) imidazole. Seal
the flask with a septum, flush with an argon flow for ∼10 min, and then add 2 mL of
dry DMF with a 5-mL glass syringe. Shake to dissolve the solids.
6. Cool the solution prepared in step 5 to 0°C. Add the reaction mixture obtained in step
4 with a 5-mL glass syringe very slowly (over at least a 30-min period) and stir the
resulting solution at 0°C for 5 hr.
7. Add 30 mL CH2Cl2 and 50 mL of 5% citric acid, transfer the mixture to a 250-mL
separatory funnel, and separate the organic phase.
8. Extract the aqueous phase four times with 30 mL CH2Cl2.
9. Combine the organic phases, dry over ∼2 g anhydrous Na2SO4, and filter off the solids
using a filter funnel and Whatman no. 1 filter paper. Concentrate the filtrate to dryness
on a rotary evaporator with a water aspirator.
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10. Dissolve the residue in ∼8 mL of 19:1 (v/v) CHCl3/methanol and apply to the top of
a 3.0 × 12–cm flash chromatography column (APPENDIX 3E) prepared with a slurry of
40-µm silica gel in the same solvent system. Elute the column with the same solvent
system. Monitor the fractions by TLC (APPENDIX 3D) using 9:1 (v/v) CHCl3/methanol.
11. Pool the fractions that contain the UV-active spot with an Rf = 0.5 (9:1 CHCl3/metha-
nol), concentrate to dryness on a rotary evaporator, and then dry under vacuum.
The product, (S.6), has the highest Rf value, and is the major UV-active spot in the reaction
mixture under these TLC conditions. The expected yield is 92% (839 mg). 1H NMR (CDCl3,
500 MHz) δ 0.88-1.01 (m, 14H), 1.24-1.27 (m, 12H), 1.32 (s, 9H), 1.47-1.53 (m, 2H),
1.65-1.85 (m, 6H), 2.18-2.31 (m, 4H), 3.03-3.10 (m, 2H), 3.25 (dt, 1H, J = 7.4, 4.7 Hz),
3.38-3.50 (m, 4H), 3.54-3.56 (m, 4H), 3.60 (s, 4H), 4.14-4.27 (m, 9H), 5.22-5.24 (m, 1H),
6.37 (t, 1H, J = 5.5 Hz), 6.58 (t, 1H, J = 5.3 Hz), 7.39 (d, 2H, J = 8.5 Hz), 7.57 (d, 2H, J
= 8.5 Hz); 13C NMR (CDCl3, 500 MHz) δ 13.4, 14.2, 17.7, 27.8, 29.8, 30.5, 31.3, 32.0,
35.1, 35.6, 38.4, 39.2, 39.5, 40.0, 55.2, 57.5, 61.6, 61.7, 61.8, 62.7,70.0, 70.1 (X 2), 70.3,
73.8, 124.7, 129.1, 131.9, 155.1, 156.3, 169.2, 170.2, 173.3, 174.2.
Prepare biotin diethyl bis(hydroxymethyl)malonate conjugate phosphoramidite S.7
12. Dry 715 mg (0.72 mmol) S.6 in a 50-mL oven-dried, one-neck round-bottomed flask
(equipped with a magnetic stir bar) under vacuum overnight at room temperature.
13. Flush the flask with an argon flow for ∼5 min, then sequentially add 2 mL dry
acetonitrile and 264 µL (0.80 mmol) 2-cyanoethyl-N,N,N′,N′-tetraisopropylphos-
phoramidite with a 5-mL and 500-µL glass syringe, respectively.
14. Add 1.68 mL (0.76 mmol) of 0.45 M 1H-tetrazole (in acetonitrile) with a 5-mL glass
syringe, stir the mixture at room temperature for 3 hr, and then quench the reaction
with 50 mL of 5% NaHCO3.
15. Transfer the reaction mixture to a 250-mL separatory funnel, extract the mixture five
times with 30 mL CH2Cl2, and combine the organic phases.
16. Dry over ∼2 g anhydrous Na2SO4, filter off the solids, and concentrate the filtrate to
dryness on a rotary evaporator.
17. Dissolve the residue in ∼5 mL of 7:3:0.5 (v/v/v) CHCl3/THF/TEA, and apply to the
top of a 3.0 × 10–cm flash chromatography column prepared with a slurry of silica
gel in the same solvent. Elute the column with the same solvent system and monitor
the fractions by TLC.
18. Pool the fractions that contain the UV-active spot with an Rf = 0.5 (7:3:0.5
CHCl3/THF/TEA), remove solvents on a rotary evaporator, and dry under vacuum.
S.7 is obtained as a white foam with an expected yield of 61% (520 mg). 1H NMR (CDCl3,
250 MHz) δ 0.91-1.07 (m, 14H), 1.14-1.18 (m, 12H), 1.22-1.29 (m, 12H), 1.32 (s, 9H),
1.41-1.51 (m, 2H), 1.65-1.82 (m, 4H), 2.16-2.34 (m, 4H), 2.60 (t, 2H, J = 6.8 Hz), 3.04-3.06
(m, 2H), 3.21-3.26 (m, 1H), 3.40-3.48 (m, 4H), 3.52-3.61 (m, 8H), 3.76-3.82 (m, 2H),
4.05-4.25 (m, 11H), 5.19-5.22 (m, 1H), 6.28 (t, 1H, J = 5.5 Hz), 6.39 (t, 1H, J = 5.3 Hz),
7.39 (d, 2H, J = 8.0 Hz), 7.57 (d, 2H, J = 8.3 Hz); 31P NMR (CDCl3, 250 MHz) δ 166.36.
Synthesize biotinylated DNA
19. Perform oligonucleotide synthesis, coupling of the biotinylated phosphoramidite S.7,
and cleavage and deprotection of the biotinylated DNA (S.8) as described (see Basic
Protocol 1, steps 18 to 23).
For the example in Figure 4.20.3 (S.9), the sequence 3′-TCAGTGACA-5′ was synthesized
on a 1-mol scale prior to biotinylation. The HPLC profile of crude biotinylated S.9 is
illustrated in Figure 4.20.2.
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SUPPORT
PROTOCOL 1
APPLICATION OF THE REVERSIBLE BIOTINYLATION METHOD IN 
AFFINITY PURIFICATION USING AVIDIN-COATED MICROSPHERES
This protocol describes the attachment of the reversibly biotinylated full-length DNAs
S.4 and S.8 (see Figs. 4.20.1 and 4.20.3, respectively) to NeutrAvidin-coated micro-
spheres, the removal of nonbiotinylated failure sequences resulting from inefficient
coupling and other impurities, and the recovery of pure, unmodified DNAs S.10 and S.12
(see Fig. 4.20.4) from the solid microspheres.
Materials
UltraLink Immobilized NeutrAvidin (1000-Å pore size; 50- to 80-µm particle size;
0.08 µmol biotin/ml gel binding capacity; Pierce), prepared as 50% (v/v) slurry
containing 0.02% (w/v) sodium azide
PBS (APPENDIX 2A)
Biotinylated DNA (see Basic Protocol 1 for S.4 or Basic Protocol 2 for S.8)
Acetone (dried over anhydrous sodium sulfate)
Tetrahydrofuran (THF, distilled over sodium/benzophenone ketyl)
70:30 (v/v) hydrogen fluoride in pyridine (HF/pyridine)
Methoxytrimethylsilane
∼40% (v/v) methylamine (CH3NH2; for 5′-phosphate DNA S.8 only)
10- and 1.5-mL centrifuge tubes
Lyophilizer or Speedvac evaporator
1. Transfer 5 mL (for 1-µmol scale DNA synthesis) UltraLink Immobilized Neutr-
Avidin gel (i.e., 10 mL of 50% gel slurry) into a 10-mL centrifuge tube, centrifuge
30 sec at 2100 × g, room temperature, and remove the supernatant.
2. Resuspend the gel in 5 mL PBS, centrifuge 30 sec at 2100 × g, room temperature,
and remove the supernatant. Repeat wash two additional times.
3. Dissolve 1 µmol biotinylated DNA in 2 mL PBS and transfer the solution to the
centrifuge tube containing the NeutrAvidin gel. Wash the DNA tube two times with
0.5 mL PBS and add to the gel suspension. Incubate at room temperature for 1 hr
with occasional gentle shaking.
4. Centrifuge the suspension 30 sec at 2100 × g, room temperature, and remove the
supernatant. Wash and then dry the gel as follows:
at least three times with 3 mL PBS
three times with 3 mL water
two times with 5 mL acetone
three times with 5 mL THF.
5. Suspend the gel in 5 mL THF, add 300 µL of 70:30 (v/v) HF/pyridine with a 500-µL
pipet, and incubate the suspension 1 hr at room temperature with occasional gentle
shaking.
The fluoride ion cleaves the two Si-O bonds in S.4 and S.8 (see Fig. 4.20.4).
CAUTION: HF reacts with glass and is toxic. The reaction must be performed in a plastic
centrifuge tube in a well-ventilated fume hood.
6. Add 3 mL methoxytrimethylsilane with a 1-mL pipet, incubate at room temperature
for 10 min, and then centrifuge the mixture 30 sec at 2100 × g and discard the
supernatant.
Methoxytrimethylsilane quenches the excess HF, giving the volatile side products fluoro-
trimethylsilane and methanol (see Fig. 4.20.4).
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7a. For 5′-OH DNA (from S.4): Collect pure DNA S.10 by washing the gel six times with
0.5 mL water, saving each wash. Combine water washes and dry in a Speedvac
evaporator or lyophilizer.
Expected recovery yield is >80%. The purity of the DNA can be checked by reversed-phase
HPLC (UNIT 10.5). A typical profile for the short sequence 5′-TACAGTGACT-3′ is illustrated
in Figure 4.20.2.
7b. For 5′-phosphate DNA (from S.8): Wash the gel with 1 mL THF, then add 3 mL of
∼40% methylamine and incubate at room temperature for 30 min. Centrifuge the
mixture 30 sec at 2100 × g, remove the supernatant, and wash the gel seven times
with 1 mL water, saving each wash. Combine the supernatant and water washes, and
dry the pure DNA S.12 in a Speedvac evaporator or lyophilizer.
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Figure 4.20.4 Removal of biotin from biotinylated DNAs S.4 and S.8 to generate unmodified 5′-OH
DNA S.10 and unmodified 5′-phosphate DNA S.12, respectively.
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Aqueous methylamine removes the 5′-tag in S.11 to generate the 5′-phosphate DNA S.12
(see Fig. 4.20.4). Expected recovery yield is >70%. The purity of the DNA can be checked
by reversed-phase HPLC (UNIT 10.5). A typical profile for the short sequence 5′-H2O3PO-
ACAGTGACT-3′ is illustrated in Figure 4.20.2.
SUPPORT
PROTOCOL 2
SYNTHESIS OF BIOTINYL ALCOHOL
The biotinyl alcohol S.1 is required for the preparation of the reversible biotinylation
phosphoramidites S.3 and S.7. This protocol describes its preparation, which is shown in
Figure 4.20.5.
Additional Materials (also see Basic Protocol 1)
Levulinic acid (98%)
Dry ice/acetone
3.0 M methyl magnesium bromide in ether
Acetic acid (99.7%+)
Magnesium sulfate (MgSO4, anhydrous)
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Figure 4.20.5 Preparation of the biotinyl alcohol S.1.
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2,2′-(Ethylenedioxy)bis(ethylamine) (98%)
Ether
Triethylamine 
Ninhydrin
Ethanol (anhydrous)
Biotin (AnaSpec)
4-(Dimethylamino)pyridine (DMAP)
Pyridine (distilled from CaH2)
t-Butylchlorodiphenylsilane (98%)
4-t-Butylbenzoylchloride (98%)
Potassium carbonate (K2CO3)
5% citric acid
Isobutylchloroformate (98%)
100-, 20-, 10-, 5-, and 1-mL graduated glass syringes
1000-mL two-neck round-bottomed flask, oven dried
Condenser
500- and 250-mL separatory funnels
Aldrich short-path distillation apparatus
50-, 100- and 250-mL one-neck round-bottomed flasks, oven dried
Flash chromatography columns (4.5 × 30–cm and 4.5 × 10–cm)
Heat gun
Rubber septum
2- and 6-cm stainless steel needles
Prepare lactone S.13
1. Add 14 mL (300 mmol) levulinic acid and 300 mL THF with a 20-mL and 100-mL
glass syringe, respectively, to a 1000-mL oven-dried, two-neck, round-bottomed flask
equipped with a magnetic stir bar, connected to an argon flow through a condenser.
2. Cool the flask to −78°C with a slurry of dry ice in acetone. Slowly add 100 mL (300
mmol) of 3.0 M methyl magnesium bromide in ether with a 100-mL glass syringe.
Stir the mixture for 3 hr while gradually warming to room temperature, then heat to
50°C overnight.
This should form a light yellow solution.
3. Cool the solution to room temperature, add ∼100 mL acetic acid with a disposable
pipet, and stir the mixture for ∼12 hr.
At this stage, maintaining an anhydrous atmosphere is unnecessary.
4. Add 40 mL water and then remove volatile components (ether and THF) on a rotary
evaporator.
5. Transfer the red residue to a 500-mL separatory funnel and extract three times with
100 mL (each extraction) CH2Cl2.
6. Combine the organic phases, dry over ∼5 g anhydrous MgSO4, and filter off the solids.
Concentrate the filtrate on a rotary evaporator.
7. Distill the residue by means of a short-path distillation apparatus using a vacuum of
∼0.6 mmHg. Collect the second fraction, which typically distills at 70°C (∼0.6
mmHg).
The product 5,5-dimethyl-dihydrofuran-2-one (S.13) should be a colorless oil with an
expected yield of 61% (9.5 g). 1H NMR (CDCl3, 250 MHz): δ 1.44 (s, 6H), 2.06 (t, 2H, J
= 8.23 Hz), 2.63 (t, 2H, J = 8.3 Hz).
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Prepare amino alcohol S.14
8. Place 24.3 mL (166 mmol) 2,2′-(ethylenedioxy)bis(ethylamine), 9.5 g (83.2 mmol)
S.13, and 10 mL water in a 100-mL one-neck, round-bottomed flask equipped with
a condenser and a magnetic stir bar. Stir the mixture overnight at 90°C.
This should give a light yellow solution.
9. Remove water and excess 2,2′-(ethylenedioxy)bis(ethylamine) by distilling at ∼70°C
at 0.6 mmHg under vacuum as in step 7.
10. Dissolve the light yellow oily residue in 15 mL of 5:2:2:1 (v/v/v/v) ether/metha-
nol/acetonitrile/triethylamine and apply the solution to the top of a 4.5 × 30–cm flash
chromatography column prepared using a slurry of silica gel in the same solvent
mixture. Elute the column and monitor the fractions by TLC using the same solvent
mixture. Detect the product by rinsing the TLC plate briefly in a solution of 0.5 g
ninhydrin in 200 mL ethanol and heat with a heat gun until purple spots appear (∼45
sec).
The product should appear as a purple spot with an Rf = 0.8.
11. Pool the fractions containing the pure product, evaporate solvents on a rotary
evaporator, and dry the light yellow oily product under vacuum.
The expected yield of the product (S.14) is 75% (16.3 g). 1H NMR (CD3OD, 500 MHz): δ
1.20 (s, 6H), 1.78 (t, 2H, J = 8.1 Hz), 2.35 (t, 2H, J = 7.5 Hz), 2.88 (t, 2H, J = 4.5 Hz),
3.89-3.42 (m, 2H), 3.54-3.57 (m, 4H), 3.62 (s, 4H); 13C NMR (CD3OD, 500 MHz): δ 28.8,
31.0, 38.5, 38.8, 40.8, 69.0, 69.3, 69.6, 69.7, 72.0, 174.0.
Prepare N-t-butylbenzoylbiotin S.16
12. Place 2.44 g (10.0 mmol) biotin and 0.61 g (5.0 mmol) DMAP in a 250-mL
oven-dried, one-neck, round-bottomed flask equipped with a magnetic stir bar and
capped with a rubber septum. Connect the flask to an argon flow with a 2-cm stainless
steel needle and flush the flask with argon for ∼5 min.
13. Sequentially add 15 mL dry pyridine and 3.0 mL (15 mmol) t-butylchlorodiphenyl-
silane with a 20- and 5-mL glass syringe, repectively, and stir the mixture overnight
at room temperature.
t-Butylchlorodiphenylsilane is used for temporary protection of the carboxylic acid group
to form the intermediate S.15.
14. Add 3.0 mL (15 mmol) 4-t-butylbenzoylchloride with a 5-mL glass syringe, stir the
mixture for 3 hr, and then quench the reaction by adding 2 mL methanol.
15. Remove volatile components on a rotary evaporator. Dissolve the residue in a mixture
of the following:
12 mL THF
6 mL methanol
6 mL water
6.9 g (50 mmol) K2CO3.
Stir 30 min at room temperature.
This mild basic condition removes the t-butyldiphenylsilane group without affecting the
4-t-butylbenzoyl protecting group, to give S.16.
16. Quench the reaction with 50 mL of 5% citric acid. Extract the mixture six times with
20 mL ethyl acetate. Combine the organic extracts, dry over ∼2 g anhydrous MgSO4,
filter off the solids, and concentrate the filtrate to dryness on a rotary evaporator.
Current Protocols in Nucleic Acid Chemistry Supplement 14
4.20.13
Synthesis of
Modified
Oligonucleotides
and Conjugates
17. Dissolve the residue in ∼4 mL CHCl3, place the solution on top of a 4.5 × 10–cm
flash chromatography column, and elute first with ∼350 mL CHCl3 and then with
19:1 (v/v) CHCl3/methanol. Monitor the fractions by TLC using 9:1:10 (v/v/v)
CHCl3/methanol/ether as the solvent system.
18. Pool fractions that contain the UV-active spot with an Rf = 0.5 (9:1:10 CHCl3/metha-
nol/ether), concentrate to dryness on a rotary evaporator, and dry under vacuum.
The expected yield of the product 1-(4-tert-butylbenzoyl)-biotin (S.16) is 76% (3.07 g). 1H
NMR (CD3OD, 500 MHz) δ 1.15 (s, 9H), 1.27-1.63 (m, 6H), 2.14 (t, 2H, J = 7.4 Hz),
2.79-2.91 (m, 2H), 3.11-3.15 (m, 1H), 4.07 (dd, 1H, J = 4.6, 7.8 Hz), 4.98-5.00 (m, 1H),
7.25 (d, 2H, J = 8.5 Hz), 7.31 (d, 2H, J = 8.6 Hz); 13C NMR (CD3OD, 500 MHz) δ 26.1,
29.6, 29.9, 31.7, 34.8, 35.9, 38.9, 56.7, 59.3, 64.1, 125.7, 129.8, 133.8, 156.1, 158.2, 171.9,
177.6.
19. Place 1.9 g (4.8 mmol) S.16 in a 100-mL one-neck, round-bottomed flask equipped
with a magnetic stir bar. Then place 292 mg (2.39 mmol) DMAP and 656 mg (2.5
mmol) S.14 in a separate 50-mL one-neck, round-bottomed flask equipped with a
stir bar. Dry both on a vacuum pump overnight at room temperature.
Prepare biotinyl alcohol S.1
20. Stop the neck of the flask containing S.16 with a rubber septum. Flush the flask with
an argon flow with two 6-cm stainless steel needles (one inlet and one outlet) for ∼10
min and then remove the outlet needle.
21. Place the flask in an ice bath and sequentially add 4 mL dry DMF and 920 µL (5.28
mmol) DIEA with a 5-mL and 1-mL glass syringe, respectively. Let sit 10 min.
22. Add 684 µL (5.27 mmol) isobutylchloroformate with a 1-mL glass syringe and stir
the mixture 1 hr at 0°C.
This forms the intermediate S.17.
23. Flush the flask containing DMAP and S.14 (step 19) with an argon flow for 10 min,
then add 4 mL dry DMF with a 5-mL glass syringe.
24. Very slowly add the solution of DMAP and S.14 to the solution of intermediate S.17
with a 10-mL glass syringe (at least over a 15-min period). After addition, stir the
mixture 10 min at 0°C.
25. Quench the reaction with 2 mL water. Add 20 mL of 5% citric acid, transfer the
mixture to a 250-mL separatory funnel, and extract six times with 30 mL (each
extraction) ethyl acetate.
26. Pool the extracts, dry over ∼2 g anhydrous Na2SO4, filter off the solids, and evaporate
the filtrate on a rotary evaporator.
27. Dissolve the residue in ∼10 mL of 19:1 (v/v) CH2Cl2/methanol and apply to the top
of a 4.5 × 10–cm flash chromatography column prepared with a slurry of silica gel
in the same solvent. Elute the column with the same solvent and monitor the fractions
by TLC using a solvent system of 9:1 (v/v) CH2Cl2/methanol.
28. Collect the fractions that contain a UV-active spot with an Rf = 0.5 (9:1 CH2Cl2/metha-
nol), pool these fractions, and evaporate to dryness on a rotary evaporator to give S.1.
Under vacuum, biotinyl alcohol (S.1) can form a white foam. Expected yield is 66% (2.1
g). 1H NMR (CD3OD, 500MHz) δ 1.24 (s, 6H), 1.38 (s, 9H), 1.46-1.55 (m, 2H), 1.65-1.85
(m, 6H), 2.28 (t, 2H, J = 7.3 Hz), 2.34 (t, 2H, J = 7.7 Hz), 3.06-3.13 (m, 2H), 3.36-3.43
(m, 5H), 3.55-3.66 (m, 8H), 4.31 (t, 1H, J = 6.9 Hz), 5.22 (t, 1H, J = 6.6 Hz), 7.48 (d, 2H,
J = 8.2 Hz), 7.54 (d, 2H, J = 8.1 Hz); 13C NMR (CD3OD, 500 MHz) δ 26.9, 29.3, 29.5,
29.9, 31.8, 32.4, 35.9, 36.8, 38.9, 40.3, 40.4, 40.4, 56.7, 59.3, 64.0, 70.7, 70.7, 70.9, 71.4,
79.6, 125.6, 129.8, 133.7, 156.1, 158.1, 171.8, 176.1, 176.6.
Supplement 14 Current Protocols in Nucleic Acid Chemistry
4.20.14
Reversible
Biotinylation of
the 5′-Terminus
of Oligodeoxy-
ribonucleotides
COMMENTARY
Background Information
The strong noncovalent highly specific in-
teraction between biotin and streptavidin or
avidin (association constant = 1015/M) has
found numerous applications in areas such as
immunology, cell biology, and molecular biol-
ogy (McInnes and Symons, 1989). Conse-
quently, many methods have been developed
for biotinylation of various target molecules.
Biotinylation of DNA has been achieved either
enzymatically (Langer et al., 1981) or chemi-
cally. Site-specific chemical biotinylation of
DNA can be performed manually after solid-
phase synthesis, cleavage, and complete depro-
tection (Agrawal et al., 1986; Urdea et al., 1988;
Gildea et al., 1990; De Vos et al., 1994) or
automatically by the synthesizer during solid-
phase synthesis (Pon, 1991; Neuner, 1996; Ole-
jnik et al., 1996). For the latter method, which
is more convenient to perform, biotinylation
reagents that are compatible with DNA synthe-
sis, cleavage, and deprotection conditions are
required.
For some applications, releasing the target
DNA from streptavidin or avidin may be nec-
essary. For this purpose, cleavable linkers have
been incorporated in between biotin and target
DNA to avoid the harsh conditions required for
breaking the biotin-streptavidin/avidin bond-
ing. For example, a disulfide bond has been
incorporated into the linker, which can be bro-
ken by reduction with dithiothreitol (Shimkus
et al., 1985; Dawson et al., 1991). The draw-
back of this method is that part of the linker is
left on the oligonucleotide, therefore modify-
ing the oligonucleotide, which may not be fur-
ther processed under biological and biochemi-
cal conditions. Another method is to incorpo-
rate an acid-labile linker in between biotin and
DNA (Gildea et al., 1990). Although the DNA
is not modified after cleavage from biotin, the
synthesis of the reagent for biotinylation is
complicated, and biotinylation is performed
manually. A third method uses a photocleavable
linkage between biotin and DNA (Olejnik et
al., 1996). Using this method, biotinylation is
performed automatically by the synthesizer
during solid-phase synthesis and, after cleav-
age, unmodified DNA is obtained. The unsat-
isfactory feature of this method is that target
DNA may be damaged by UV irradiation dur-
ing photocleavage (Cadet and Vigny, 1990;
Greenberg and Gilmore, 1994; Greenberg,
1995).
The biotinylation methods described in this
unit use a fluoride-cleavable diisopropyl silyl
acetal linkage between biotin and DNA (Fang
and Bergstrom, 2003a,b). This method has sev-
eral advantages over known methods. The bio-
tinylation is automatically carried out by the
synthesizer during solid-phase synthesis, no
damage of target DNA during cleavage should
occur, and, after cleavage, both unmodified
5′-OH (Fang and Bergstrom, 2003b) and un-
modified 5′-phosphate DNA (Fang and
Bergstrom, 2003a) can be obtained depending
on which of the two phosphoramidites is used
(see Figs. 4.20.1, 4.20.3, and 4.20.4).
One of the potential applications of this
reversible biotinylation method is affinity pu-
rification of synthetic oligonucleotides medi-
ated by biotin-avidin/streptavidin binding, as
demonstrated in Support Protocol 1. The bio-
tinylated full-length DNA can be readily at-
tached to the NeutrAvidin-coated micro-
spheres, nonbiotinylated failure sequences and
other impurities can be removed by simply
washing with buffer and water, and high-qual-
ity unmodified DNA can be obtained by simple
incubation with fluoride ions (followed by
aqueous amine treatment in the case of 5′-phos-
phorylated DNA; Guzaev et al., 1995) under
mild conditions, followed by a water wash (see
Fig. 4.20.4). Currently, synthetic DNA is gen-
erally purified by HPLC and/or gel electropho-
resis, which are considered time consuming.
DMTr-selective cartridge purification is con-
venient, but the quality of DNA thus obtained
is less satisfactory (UNIT 10.7). The affinity puri-
fication method described in this unit is con-
venient, and high quality DNA can be obtained.
It is anticipated that the advantages of this
method will be more obvious when it is re-
quired for purification of very long DNA se-
quences and/or isolation of target DNA from
very complex mixtures.
Critical Parameters and
Troubleshooting
For the preparation of the two phos-
phoramidites (S.3 and S.7, see Basic Protocols
1 and 2 and Support Protocol 2), many steps
must be carried out under strict anhydrous con-
ditions. When this is the case, make certain that
glassware and reagents, especially solvents, are
dry. Although some reactions can be performed
in open air, the authors recommend all trans-
formations be performed under an argon or
nitrogen atmosphere.
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The oligonucleotide to be biotinylated must
be synthesized using acetyl-protected C rather
than benzoyl-protected C; otherwise, transami-
nation may occur during the aqueous
CH3NH2/NH4OH cleavage/deprotection
(Reddy et al., 1994; Wincott et al., 1995).
When using the biotinylation method for
affinity purification of synthetic oligonu-
cleotides, make sure to handle the NeutrAvidin-
coated microspheres gently. Vortexing of the
gel should be avoided, as this may result in
leaking of gel material and low recovery yield
of full-length DNA.
Anticipated Results
Yields reported for each step during the
preparation of the phosphoramidites S.3 and
S.7 may vary depending on how carefully the
reaction, work-up, and purification are per-
formed. Since these reactions can be easily
performed on a gram scale, it is not difficult to
obtain sufficient amounts of S.3 and S.7 for
biotinylating several batches of DNA. The yield
for biotinylation of the 5′-end of DNA on solid
support is >99% in each case. For affinity pu-
rification by a NeutrAvidin-coated gel, a recov-
ery yield of full-length unmodified DNA can
be >70% in both cases.
Time Considerations
The preparation of the phosphoramidites S.3
or S.7 requires ∼13 days including drying glass-
ware and reagents, setting up and working up
reactions, and purifying and drying products.
DNA synthesis, 5′-biotinylation, and postsyn-
thetic cleavage/deprotection can be achieved in
1 or 2 days depending on the length of the
sequence. Affinity purification can be carried
out within 6 hr, but drying the product may
require ∼12 hr.
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